Crispr Therapeutics Ag (CRSP)

Working Capital Ratio

84.46%

Quarterly · Period ending:

CRSP logo

CRSP Working Capital Ratio

Latest reported81.08%
CRSP FY Working Capital Ratio (-77.14% → 81.08%)
High-resolution chart · PNG

CRSP working capital ratio history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag Working Capital Ratio — Annual fiscal periods
Period endingWorking Capital Ratio
81.0752%
82.4854%
80.701%
77.2124%
83.4932%
88.7523%
87.2219%
89.7003%
86.1903%
86.4414%
92.0099%
-77.1447%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.